Therma Bright Inc (THRM) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Therma Bright Inc (THRM) has a cash flow conversion efficiency ratio of 0.026x as of October 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CA$-38.76K ≈ $-28.04K USD) by net assets (CA$-1.52 Million ≈ $-1.10 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Therma Bright Inc - Cash Flow Conversion Efficiency Trend (2001–2025)
This chart illustrates how Therma Bright Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data. Read THRM total debt and obligations for a breakdown of total debt and financial obligations.
Therma Bright Inc Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Therma Bright Inc ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Cariboo Rose Resources Ltd
V:CRB
|
0.180x |
|
Netcall plc
LSE:NET
|
0.012x |
|
GIGLIO GROUP S.P.A. O.N.
F:5JR
|
N/A |
|
Range International Ltd
AU:RAN
|
-0.462x |
|
James Latham PLC
LSE:LTHM
|
0.049x |
|
Australian Silica Quartz Group Ltd
F:4B4
|
-0.076x |
|
Superior Industries International
NYSE:SUP
|
0.139x |
|
Supply@Me Capital PLC
LSE:SYME
|
0.084x |
Annual Cash Flow Conversion Efficiency for Therma Bright Inc (2001–2025)
The table below shows the annual cash flow conversion efficiency of Therma Bright Inc from 2001 to 2025. For the full company profile with market capitalisation and key ratios, see Therma Bright Inc stock valuation.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-07-31 | CA$-1.57 Million ≈ $-1.13 Million |
CA$-146.53K ≈ $-106.00K |
0.094x | +112.28% |
| 2024-07-31 | CA$1.32 Million ≈ $958.00K |
CA$-1.01 Million ≈ $-730.10K |
-0.762x | +98.43% |
| 2023-07-31 | CA$44.79K ≈ $32.40K |
CA$-2.17 Million ≈ $-1.57 Million |
-48.555x | -3410.13% |
| 2022-07-31 | CA$2.75 Million ≈ $1.99 Million |
CA$-3.80 Million ≈ $-2.75 Million |
-1.383x | +36.29% |
| 2021-07-31 | CA$1.32 Million ≈ $951.41K |
CA$-2.86 Million ≈ $-2.07 Million |
-2.171x | -363.35% |
| 2020-07-31 | CA$223.97K ≈ $162.01K |
CA$-104.94K ≈ $-75.91K |
-0.469x | -170.73% |
| 2019-07-31 | CA$-286.40K ≈ $-207.18K |
CA$-189.72K ≈ $-137.24K |
0.662x | -86.82% |
| 2018-07-31 | CA$-71.59K ≈ $-51.79K |
CA$-359.89K ≈ $-260.34K |
5.027x | +2417.45% |
| 2017-07-31 | CA$-893.85K ≈ $-646.59K |
CA$-178.49K ≈ $-129.11K |
0.200x | +601500.19% |
| 2016-07-31 | CA$-1.63 Million ≈ $-1.18 Million |
CA$54.00 ≈ $39.06 |
0.000x | -100.22% |
| 2015-07-31 | CA$-1.42 Million ≈ $-1.03 Million |
CA$-21.43K ≈ $-15.50K |
0.015x | +50.83% |
| 2014-07-31 | CA$-5.52 Million ≈ $-3.99 Million |
CA$-55.16K ≈ $-39.90K |
0.010x | -33.21% |
| 2013-07-31 | CA$-5.62 Million ≈ $-4.06 Million |
CA$-84.10K ≈ $-60.84K |
0.015x | +22658.84% |
| 2012-07-31 | CA$-6.61 Million ≈ $-4.78 Million |
CA$-435.00 ≈ $-314.67 |
0.000x | -97.60% |
| 2011-07-31 | CA$-5.83 Million ≈ $-4.22 Million |
CA$-16.00K ≈ $-11.57K |
0.003x | -78.02% |
| 2009-07-31 | CA$-5.03 Million ≈ $-3.64 Million |
CA$-62.68K ≈ $-45.34K |
0.012x | -87.91% |
| 2008-07-31 | CA$-3.54 Million ≈ $-2.56 Million |
CA$-365.58K ≈ $-264.45K |
0.103x | -61.80% |
| 2007-07-31 | CA$-2.00 Million ≈ $-1.44 Million |
CA$-539.12K ≈ $-389.99K |
0.270x | -69.93% |
| 2006-07-31 | CA$-1.46 Million ≈ $-1.06 Million |
CA$-1.31 Million ≈ $-950.53K |
0.898x | +73.98% |
| 2005-07-31 | CA$-991.06K ≈ $-716.92K |
CA$-511.69K ≈ $-370.15K |
0.516x | -95.60% |
| 2004-07-31 | CA$-117.47K ≈ $-84.98K |
CA$-1.38 Million ≈ $-997.57K |
11.739x | +2050.43% |
| 2002-07-31 | CA$1.61 Million ≈ $1.16 Million |
CA$-968.11K ≈ $-700.31K |
-0.602x | +22.24% |
| 2001-07-31 | CA$633.46K ≈ $458.24K |
CA$-490.32K ≈ $-354.69K |
-0.774x | -- |
About Therma Bright Inc
Therma Bright Inc. acquires, develops, manufactures, and markets proprietary healthcare and medical devices focused on respiratory diseases, vascular health, and consumer medical devices for consumer and institutional marketplace. Its products include AcuVid, an antigen and antibody rapid screening test for COVID-19; InterceptCS, a cold sore prevention system, which provides controlled topical he… Read more